Ten years of work, along with a little help from the green mamba snake, have resulted in a promising new drug for multiple sclerosis that is already being tested in clinical trials. …
A newly developed antimicrobial compound effectively clears bacterial infections in mice, including those that can result in rare but potentially fatal “flesh-eating” illnesses. …
A specific bacterium, Alcaligenes faecalis (A. faecalis), can help heal hard-to-treat wounds in people with diabetes. …
Researchers find that blocking an overproduced channel protein could significantly improve symptoms in an animal model of multiple sclerosis. …
A new preclinical model offers a unique platform for studying the Parkinson’s disease process and suggests a relatively easy method for detecting the disease in people. …
Random mixtures of antimicrobial peptides are more effective than individual peptides in reducing the risk of antibiotic resistance, underscoring the need for innovative strategies to address bacterial resistance and safeguard public health. …
Switching off interleukin 11 (IL-11), an inflammatory protein, can increase the healthy lifespan of mice by almost 25 percent. …
Elimination of solid tumors by immunotherapy requires a triad of different immune cells collaborating together: one dendritic cell, one cytotoxic (“killer”) T cell, and one helper T cell. …
Researchers successfully restored hearing in adult mice with inherited hearing loss by using gene editing to deactivate a mutated microRNA gene. …
New study shows that brain inflammation caused by infections and neurodegenerative diseases releases interleukin-6, which travels from the brain to the muscles and leads to a loss of muscle function. …
End of content
End of content
